Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

3M granted FDA approval for cream to treat superficial basal cell carcinoma

3M announced today that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of nonmelanoma skin cancer.

16 Jul 2004

New minimally invasive surgery - flexible transgastric peritoneoscopy, or FTP

Surgeries performed with specialized medical devices requiring only small incisions, called laparoscopic surgery, have many advantages over traditional open surgery, including less pain, fewer complications and quicker recoveries.

7 Jul 2004

New technology acts as third eye during breast biopsies

Doctors currently use X-ray or ultrasound - two-dimensional pictures - to guide the biopsy needle into a three-dimensional region. To ensure that they are doing the biopsy at the right spot, they take up to a dozen tissue samples.

7 Jul 2004

Chromosomal chaos in early embryonic development is linked to abnormalities in cytokinesis and spindle formation

Abnormalities in the spindles (the bi-polar thread like structures that link and pull the chromosomes during cell division) of human embryos before implantation may be the primary reason for many of the chromosome defects observed in early human development

29 Jun 2004

Gene chip technology can detect one of the commonest cystic fibrosis (CF) genetic mutations with 100% accuracy

A single genetic test that is capable of detecting all mutations involved in the development of cystic fibrosis could be just a few years away, the 20th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday 28 June).

28 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

Sirolimus-based therapy following early cyclosporine withdrawal improves transplanted kidney structure and function

Kidney histology and function three years after transplantation are better in kidney-transplant patients who remain on sirolimus-based therapy following early withdrawal of cyclosporine than in patients who continue on this calcineurin inhibitor, according to a new study published in the American Journal of Transplantation.

11 Jun 2004

Magnetic resonance imaging better than traditional mammography for detecting the presence of breast cancer

Researchers from the Abramson Cancer Center of the University of Pennsylvania today presented the first comprehensive study results which show that magnetic resonance imaging (MRI) is significantly better than traditional mammography for detecting the presence and extent of disease in patients with a diagnosis of breast cancer.

10 Jun 2004

New statistical techniques for cancer diagnosis

CSIRO statisticians have developed a new way to subtype paediatric Acute Lymphoblastic Leukaemia (ALL), the most common form of cancer in children under 12.

9 Jun 2004

Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer

Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer, according to a new study by Oregon Health & Science University Cancer Institute researchers.

9 Jun 2004

Uterine cancer, also called endometrial cancer, will strike more than 40,000 U.S. women annually

A Gynecologic Oncology Group (GOG) study, headed by Cornelia Trimble, M.D. of the Johns Hopkins Kimmel Cancer Center, has revealed that pathologists who evaluate uterine biopsies disagree 60 percent of the time on whether the specimens contain cancerous cells.

3 Jun 2004

Dow Corning breast implant claim checks to be mailed soon

Today is the effective date in the Dow Corning bankruptcy, finally allowing injured people's claims to be processed. The court-appointed claims administrator for the $2.35 billion fund said that thousands of letters will go out June 1st and that the first checks should be mailed June 15th.

2 Jun 2004

Men with low prostate specific antigen levels on screening tests can still have prostate cancer

Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study* released today by scientists from the National Cancer Institute (NCI).

27 May 2004

50 percent of British men admit they would delay seeing a doctor if they had warning signs of cancer

Younger men were most likely to cite embarrassment as a reason to delay getting their symptoms checked, whereas those in the 45+ age group were concerned about what the doctor might find as the result of an examination. Lack of time was a factor across all groups.

25 May 2004

Prostate Robotic System that will improve the diagnosis and treatment of prostate cancer

The Singapore General Hospital and Nanyang Technological University (NTU) have jointly developed a Prostate Robotic System that will improve the diagnosis and treatment of prostrate cancer, the fifth most common cancer in Singaporean men.

21 May 2004

Causes of hepatitis and potential therapies that may improve care presented in study

Hepatitis, a potentially serious disease caused by a virus that attacks the liver, is a major problem worldwide. Hepatitis A is generally food-borne, while hepatitis B and C spread primarily through parenteral or sexual routes. Hepatitis B and C can be life-long, potentially deadly chronic infections.

19 May 2004

Inexpensive, simple urine test that could identify impending kidney failure

Johns Hopkins researchers have developed the basis of an inexpensive, simple urine test that identifies impending kidney failure or rejection following transplant surgery. Their work, presented this week in a special invited lecture to the American Transplant Congress in Boston, Mass., is based on proteins found in urine, and could lead to a urine test kit that may allow many patients to skip painful biopsies.

19 May 2004

Fatty liver disease (NAFLD) in obese children has distinct characteristics different from those found in adults

Potentially life-threatening non-alcoholic fatty liver disease (NAFLD) in obese children has distinct characteristics, often different from those found in adults, according to a University of California, San Diego (UCSD) School of Medicine study led by Jeffrey Schwimmer, M.D., assistant professor of pediatrics.

19 May 2004

Obesity epidemic and its impact on prostate cancer

Recent federal reports have identified obesity as epidemic in the United States, and that that greater body mass index can be associated with a number of debilitating health conditions, such as heart disease and diabetes.

12 May 2004

Relationship between PSA score and prostate cancer has steadily declined

Results of a new study indicate that the relationship between PSA score and prostate cancer has steadily declined during the last 20 years, an important finding given that PSA score is often used to determine whether biopsy for prostate cancer testing is necessary.

10 May 2004

Biopsy News and Research

Further Reading

3M granted FDA approval for cream to treat superficial basal cell carcinoma

New minimally invasive surgery - flexible transgastric peritoneoscopy, or FTP

New technology acts as third eye during breast biopsies

Chromosomal chaos in early embryonic development is linked to abnormalities in cytokinesis and spindle formation

Gene chip technology can detect one of the commonest cystic fibrosis (CF) genetic mutations with 100% accuracy

Results from study of Rituxan in rheumatoid arthritis show promise

Sirolimus-based therapy following early cyclosporine withdrawal improves transplanted kidney structure and function

Magnetic resonance imaging better than traditional mammography for detecting the presence of breast cancer

New statistical techniques for cancer diagnosis

Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer

Uterine cancer, also called endometrial cancer, will strike more than 40,000 U.S. women annually

Dow Corning breast implant claim checks to be mailed soon

Men with low prostate specific antigen levels on screening tests can still have prostate cancer

50 percent of British men admit they would delay seeing a doctor if they had warning signs of cancer

Prostate Robotic System that will improve the diagnosis and treatment of prostate cancer

Causes of hepatitis and potential therapies that may improve care presented in study

Inexpensive, simple urine test that could identify impending kidney failure

Fatty liver disease (NAFLD) in obese children has distinct characteristics different from those found in adults

Obesity epidemic and its impact on prostate cancer

Relationship between PSA score and prostate cancer has steadily declined

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News